Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Coherus BioSciences, Inc. (CHRS)

« Back to company index

CHRS Chatter Timeline

Stock Ticker for CHRS

Most Active Tweeters for CHRS

No tweets found

Recent Tweets for CHRS

AmericanBanking @AmericanBanking
Zacks: Brokerages Expect Coherus Biosciences Inc $CHRS to Announce -$0.80 Earnings Per Share https://t.co/dxNF9edzTh #stocks
August 20th 2018, 8:08pm
ThisLincolnian @ThisLincolnian
Zacks: Brokerages Expect Coherus Biosciences Inc $CHRS to Announce -$0.80 Earnings Per Share https://t.co/2fwRZloF2o
August 20th 2018, 8:08pm
Stock_News_Now @Stock_News_Now
$CHRS: New SEC Filing for CHRS: Form CT ORDER (No. 9999999997-18-007359): https://t.co/pu3KfPT8uf
August 20th 2018, 11:08am
StockTexts @StockTexts
$CHRS Coherus BioSciences, Inc. SEC Filing: Form CT ORDER https://t.co/2em457ixSE
August 20th 2018, 11:08am
BioPharmInsight @BioPharmInsight
Read what experts have to say about $CHRS’#Neulasta and #Humira biosimilars once they hit the US market,… https://t.co/mlSiwgAdZB
August 20th 2018, 8:08am
GNWLive @GNWLive
Coherus BioSciences Management to Participate in Two Investor Healthcare Conferences in September  $CHRS https://t.co/A0HVvxFp3A
August 20th 2018, 8:08am
The_CasualSmart @The_CasualSmart
Capital International Investors Has Increased State Street $STT Position; Last Week Coherus BioSciences, Inc. $CHRS… https://t.co/uaQ3d2PVxM
August 19th 2018, 12:08pm
TheMarketsDaily @TheMarketsDaily
Coherus Biosciences Inc $CHRS Insider Sells $33,475.20 in Stock https://t.co/wQ8ydWCt9q
August 18th 2018, 11:08am
jorbis12 @jorbis12
Binance is TEMPORARILY accepting new users Register link and BONUS ? https://t.co/ye7NCHPwWW ? 08/18 07:09 $CHRS… https://t.co/bLcat25Rgj
August 18th 2018, 7:08am
stockelite @stockelite
$CHRS Coherus BioSciences Announces New Employment Inducement Grants-17-08-2018 https://t.co/NZ4KVED7U4
August 17th 2018, 5:08pm
GNWLive @GNWLive
Coherus BioSciences Announces New Employment Inducement Grants $CHRS https://t.co/hbpYOXTMuN
August 17th 2018, 5:08pm
registrarjourn @registrarjourn
Zacks: Analysts Anticipate Coherus Biosciences Inc $CHRS Will Announce Earnings of -$0.72 Per Share https://t.co/Tic9M2LILT
August 17th 2018, 4:08pm
OlympiaReport @OlympiaReport
Barbara K. Finck Sells 1,760 Shares of Coherus Biosciences Inc $CHRS Stock https://t.co/Ecg4qD2ZpA
August 17th 2018, 1:08pm
OlympiaReport @OlympiaReport
Zacks Investment Research Lowers Coherus Biosciences $CHRS to Sell https://t.co/xrm0gCp3CG
August 17th 2018, 9:08am
WeekHerald @WeekHerald
Zacks Investment Research Lowers Coherus Biosciences $CHRS to Sell https://t.co/jmzZBOZuwN
August 17th 2018, 9:08am
MareaInformativ @MareaInformativ
Coherus Biosciences Inc $CHRS Receives $27.25 Consensus Target Price from Analysts https://t.co/YFjr1ILpvv
August 17th 2018, 12:08am
ConsumerFeed @ConsumerFeed
Brokerages Set Coherus Biosciences Inc $CHRS Target Price at $27.25 https://t.co/CsiQm6jQmM
August 17th 2018, 12:08am
TranscriptDaily @TranscriptDaily
Coherus Biosciences $CHRS Cut to “Sell” at Zacks Investment Research https://t.co/ZmYOi291Lk
August 16th 2018, 4:08pm
registrarjourn @registrarjourn
Coherus Biosciences Inc $CHRS Insider Barbara K. Finck Sells 1,760 Shares of Stock https://t.co/DmsdSUFdA1
August 16th 2018, 3:08pm
EnterpriseLeade @EnterpriseLeade
Coherus Biosciences Inc $CHRS Insider Barbara K. Finck Sells 1,760 Shares of Stock https://t.co/qiE8btc9DN
August 16th 2018, 3:08pm
dispatchtribune @dispatchtribune
Insider Selling: Coherus Biosciences Inc $CHRS Insider Sells 1,760 Shares of Stock https://t.co/0DvhCXSYsT
August 16th 2018, 3:08pm
mmahotstuff1 @mmahotstuff1
1.49 is Charming Shoppes Inc's $CHRS Institutional Investor Sentiment - https://t.co/Ur01igrw9H
August 16th 2018, 8:08am
reurope_stock @reurope_stock
Charming Shoppes Inc $CHRS Shifting Institutional Investors Sentiment https://t.co/OibAzGrAU2
August 16th 2018, 8:08am
west_moreland @west_moreland
Sentiment Change Report: Charming Shoppes Inc $CHRS https://t.co/T2Rc6yd9zO
August 16th 2018, 8:08am
WeekHerald @WeekHerald
Barbara K. Finck Sells 1,760 Shares of Coherus Biosciences Inc $CHRS Stock https://t.co/iZUDFxrwrs
August 15th 2018, 8:08pm
AmericanBanking @AmericanBanking
Barbara K. Finck Sells 1,760 Shares of Coherus Biosciences Inc $CHRS Stock https://t.co/lCE9eg4YgH #stocks
August 15th 2018, 8:08pm
ThisLincolnian @ThisLincolnian
Barbara K. Finck Sells 1,760 Shares of Coherus Biosciences Inc $CHRS Stock https://t.co/Z6yizZYesb
August 15th 2018, 8:08pm
InsiderAlertsIA @InsiderAlertsIA
$CHRS: New Insider Filing on Chief Medical Officer BARBARA K FINCK: https://t.co/klY7ShHQpQ
August 15th 2018, 4:08pm
dakotafinancial @dakotafinancial
Zacks Investment Research Downgrades Coherus Biosciences $CHRS to Sell https://t.co/GVCx3mI6DQ
August 15th 2018, 5:08am
dispatchtribune @dispatchtribune
Coherus Biosciences Inc $CHRS Given Consensus Rating of “Buy” by Brokerages https://t.co/aKe1NDCbVo
August 14th 2018, 9:08pm
OlympiaReport @OlympiaReport
Coherus Biosciences Inc $CHRS Receives $27.25 Average Price Target from Analysts https://t.co/whQLBiN0CG
August 14th 2018, 9:08pm
kshahi @kshahi
$CHRS could make slow progress to low to mid $20’s leading up to PDUFA in early Nov.
August 14th 2018, 7:08pm
bioswingpattern @bioswingpattern
$CHRS 52 week closing high BB squeeze https://t.co/3C6a1bCRMB
August 14th 2018, 6:08pm
TickerReport @TickerReport
Coherus Biosciences $CHRS Rating Lowered to Sell at Zacks Investment Research https://t.co/6hJK4oYKRB
August 14th 2018, 12:08pm
WatchlistN @WatchlistN
Coherus Biosciences $CHRS Downgraded by Zacks Investment Research to “Sell” https://t.co/3S2XriSJEg
August 14th 2018, 12:08pm
bibeypost_stock @bibeypost_stock
Is there a Bearish outlook for Coherus BioSciences, Inc. $CHRS this week? - https://t.co/hWKxFDFJNJ
August 14th 2018, 6:08am
mmahotstuff1 @mmahotstuff1
Analysts take a look at Coherus BioSciences, Inc. $CHRS having this to say. - https://t.co/UjNJQ90KG6
August 14th 2018, 6:08am
reurope_stock @reurope_stock
This is what analysts have to say about Coherus BioSciences, Inc. $CHRS after last week. https://t.co/1R3PkMFJ0w
August 14th 2018, 6:08am
whatsonthorold2 @whatsonthorold2
Are Analysts Bullish about Coherus BioSciences, Inc. $CHRS after last week? - https://t.co/E4Ftc7fWhW
August 14th 2018, 6:08am
west_moreland @west_moreland
How Many Coherus BioSciences, Inc. $CHRS's Analysts Are Bearish? https://t.co/EEj4ZSAOrf
August 14th 2018, 6:08am
Fanob_stock @Fanob_stock
Is there a Bearish outlook for Coherus BioSciences, Inc. $CHRS this week? https://t.co/groncRwqbN
August 14th 2018, 6:08am
MareaInformativ @MareaInformativ
Coherus Biosciences $CHRS Lifted to Buy at ValuEngine https://t.co/77ZWcyH6g7
August 13th 2018, 9:08pm
ZolmaxNews @ZolmaxNews
Coherus Biosciences $CHRS Rating Lowered to Sell at Zacks Investment Research https://t.co/EL4yGyVw2f
August 13th 2018, 9:08pm
bibeypost_stock @bibeypost_stock
Citadel Advisors Llc Decreased Coherus Biosciences Inc $CHRS Stake By $21.90 Million - https://t.co/4aiQUUzpVF
August 12th 2018, 8:08pm
reurope_stock @reurope_stock
Citadel Advisors Llc Decreased Coherus Biosciences Inc $CHRS Stake By $21.90 Million https://t.co/WBgJeKskcV
August 12th 2018, 8:08pm
The_CasualSmart @The_CasualSmart
Citadel Advisors Llc Decreased Coherus Biosciences Inc $CHRS Stake By $21.90 Million https://t.co/Xs8aRROqkz
August 12th 2018, 8:08pm
mmahotstuff1 @mmahotstuff1
Citadel Advisors Llc Decreased Coherus Biosciences Inc $CHRS Stake By $21.90 Million - https://t.co/bQS5kt0oJz
August 12th 2018, 8:08pm
whatsonthorold2 @whatsonthorold2
Citadel Advisors Llc Decreased Coherus Biosciences Inc $CHRS Stake By $21.90 Million - https://t.co/aqTSrrDi83
August 12th 2018, 8:08pm
west_moreland @west_moreland
Citadel Advisors Llc Decreased Coherus Biosciences Inc $CHRS Stake By $21.90 Million https://t.co/gmWSJDIsXr
August 12th 2018, 8:08pm
The_CasualSmart @The_CasualSmart
Citadel Advisors Llc Decreased Coherus Biosciences Inc $CHRS Stake By $21.90 Million https://t.co/p8oTbw8slf
August 12th 2018, 8:08pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.